Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast Cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402–16.

Article  CAS  Google Scholar 

Rhiem K, Engel C, Graeser M, Zachariae S, Kast K, Kiechle M, et al. The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast Cancer Res. 2012;14(6):R156.

Article  Google Scholar 

Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, et al. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2009;27(35):5887–92.

Article  Google Scholar 

van den Broek AJ, vant’Veer LJ, Hooning MJ, Cornelissen S, Broeks A, Rutgers EJ, et al. Impact of age at primary breast Cancer on contralateral breast Cancer risk in BRCA1/2 mutation carriers. J Clin Oncol. 2016;34(5):409–18.

Article  Google Scholar 

Warner E. Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer. Cancers (Basel). 2018;10(12):477. https://doi.org/10.3390/cancers10120477. 

Bick U, Engel C, Krug B, Heindel W, Fallenberg EM, Rhiem K, et al. High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat. 2019;175(1):217–28.

Article  Google Scholar 

Evans DG, Kesavan N, Lim Y, Gadde S, Hurley E, Massat NJ, et al. MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat. 2014;145(3):663–72.

Article  Google Scholar 

Xiao YL, Wang K, Liu Q, Li J, Zhang X, Li HY. Risk reduction and survival benefit of risk-reducing Salpingo-oophorectomy in hereditary breast Cancer: Meta-analysis and systematic review. Clin Breast Cancer. 2019;19(1):e48–65.

Article  Google Scholar 

Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345(3):159–64.

Article  CAS  Google Scholar 

Heemskerk-Gerritsen BA, Rookus MA, Aalfs CM, Ausems MG, Collee JM, Jansen L, et al. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer. 2015;136(3):668–77.

CAS  Google Scholar 

Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AI, Collee M, Meijers-Heijboer HEJ, et al. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2019;177(3):723–33.

Article  CAS  Google Scholar 

McCarthy CM, Hamill JB, Kim HM, Qi J, Wilkins E, Pusic AL. Impact of bilateral prophylactic mastectomy and immediate reconstruction on health-related quality of life in women at high risk for breast carcinoma: results of the mastectomy reconstruction outcomes consortium study. Ann Surg Oncol. 2017;24(9):2502–8.

Article  Google Scholar 

Lim DW, Metcalfe KA, Narod SA. Bilateral mastectomy in women with unilateral breast Cancer: a review. JAMA Surg. 2021;156(6):569–76.

Article  Google Scholar 

den Heijer M, Seynaeve C, Timman R, Duivenvoorden HJ, Vanheusden K, Tilanus-Linthorst M, et al. Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study. Eur J Cancer (Oxford, England : 1990). 2012;48(9):1263–8.

Article  Google Scholar 

Anderson C, Islam JY, Elizabeth Hodgson M, Sabatino SA, Rodriguez JL, Lee CN, et al. Long-term satisfaction and body image after contralateral prophylactic mastectomy. Ann Surg Oncol. 2017;24(6):1499–506.

Article  Google Scholar 

Altschuler A, Nekhlyudov L, Rolnick SJ, Greene SM, Elmore JG, West CN, et al. Positive, negative, and disparate--women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 2008;14(1):25–32.

Article  Google Scholar 

Glassey R, Ives A, Saunders C, Musiello T. Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy - a review of the literature. Breast (Edinburgh, Scotland). 2016;28:130–5.

Article  Google Scholar 

Carbine NE, Lostumbo L, Wallace J, Ko H. Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev. 2018;4:CD002748.

Google Scholar 

Gahm J, Wickman M, Brandberg Y. Bilateral prophylactic mastectomy in women with inherited risk of breast cancer--prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast (Edinburgh, Scotland). 2010;19(6):462–9.

Article  Google Scholar 

Bresser PJ, Seynaeve C, Van Gool AR, Brekelmans CT, Meijers-Heijboer H, van Geel AN, et al. Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg. 2006;117(6):1675–82 discussion 83–4.

Article  CAS  Google Scholar 

Hallowell N, Baylock B, Heiniger L, Butow PN, Patel D, Meiser B, et al. Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery. Familial Cancer. 2012;11(2):215–24.

Article  Google Scholar 

Payne DK, Biggs C, Tran KN, Borgen PI, Massie MJ. Women's regrets after bilateral prophylactic mastectomy. Ann Surg Oncol. 2000;7(2):150–4.

Article  CAS  Google Scholar 

Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE, et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. 2000;284(3):319–24.

Article  CAS  Google Scholar 

Howard AF, Balneaves LG, Bottorff JL. Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review. J Genet Couns. 2009;18(6):578–97.

Article  Google Scholar 

van Dijk S, van Roosmalen MS, Otten W, Stalmeier PF. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. J Clin Oncol. 2008;26(14):2358–63.

Article  Google Scholar 

Howard AF, Balneaves LG, Bottorff JL, Rodney P. Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction. Qual Health Res. 2011;21(4):502–19.

Article  Google Scholar 

Jamal L, Schupmann W, Berkman BE. An ethical framework for genetic counseling in the genomic era. J Genet Couns. 2020;29(5):718–27.

Article  Google Scholar 

Tong A, Kelly S, Nusbaum R, Graves K, Peshkin BN, Valdimarsdottir HB, et al. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Psychooncology. 2015;24(1):33–9.

Article  Google Scholar 

van Driel CMG, Oosterwijk JC, Meijers-Heijboer EJ, van Asperen CJ, Zeijlmans van Emmichoven IA, de Vries J, et al. Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees. Breast (Edinburgh, Scotland). 2016;30:66–72.

Article  Google Scholar 

Miller SM. Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease. Implications for cancer screening and management. Cancer. 1995;76(2):167–77.

Article  CAS  Google Scholar 

Mellon S, Gold R, Janisse J, Cichon M, Tainsky MA, Simon MS, et al. Risk perception and cancer worries in families at increased risk of familial breast/ovarian cancer. Psychooncology. 2008;17(8):756–66.

Article  Google Scholar 

Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC, et al. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. Br J Cancer. 2014;110(2):535–45.

Article  CAS  Google Scholar 

Herrmann-Lingen CH, Buss U, Snaith RP. Hospital anxiety and depression scale, German version (HADS-D). 3rd ed. Bern: Hogrefe; 2011.

Google Scholar 

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

Article  CAS  Google Scholar 

Fahrenberg J, Hampel R, Selg H. Freiburger Persönlichkeitsinventar. Göttingen: Hogrefe; 2010.

Google Scholar 

O’Connor AM. Validation of a Decisional Conflict Scale. Med Decis Making. 1995;15(1):25–30. https://doi.org/10.1177/0272989X9501500105.

Katapodi MC, Munro ML, Pierce PF, Williams RA. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer. Nurs Res. 2011;60(6):368–77.

Article  Google Scholar 

Voss U, Müller H, Schermelleh-Engel K. Towards the assessment of adaptive vs. rigid coping styles: validation of the Frankfurt monitoring blunting scales by means of confirmatory factor analysis. Personal Individ Differ. 2006;41(2):295–306.

Article  Google Scholar 

Miller SM. Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat. J Pers Soc Psychol. 1987;52(2):345–53.

Article  CAS  Google Scholar 

Hinz A, Brahler E. Normative values for the hospital anxiety and depression scale (HADS) in the general German population. J Psychosom Res. 2011;71(2):74–8.

Article  Google Scholar 

Bresser PJ, Seynaeve C, Van Gool AR, Niermeijer MF, Duivenvoorden HJ, van Dooren S, et al. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. Eur J Cancer (Oxford, England : 1990). 2007;43(1):95–103.

Article  CAS  Google Scholar 

Cicero G, De Luca R, Dorangricchia P, Lo Coco G, Guarnaccia C, Fanale D, et al. Risk perception and psychological distress in genetic counselling for hereditary breast and/or ovarian Cancer. J Genet Couns. 2017;26(5):999–1007.

Article  CAS  Google Scholar 

Harmsen MG, Hermens RP, Prins JB, Hoogerbrugge N, de Hullu JA. How medical choices influence quality of life of women carrying a BRCA mutation. Crit Rev Oncol Hematol. 2015;96(3):555–68.

Article  Google Scholar 

Beran TM, Stanton AL, Kwan L, Seldon J, Bower JE, Vodermaier A, et al. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Ann Behav Med. 2008;36(2):107–16.

Article  Google Scholar 

Allford A, Qureshi N, Barwell J, Lewis C, Kai J. What hinders minority ethnic access to cancer genetics services and what may help? Eur J Hum Genet. 2014;22(7):866–74.

Article  Google Scholar 

Haroun I, Graham T, Poll A, Sun P, Hill K, Weitzner E, et al. Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer. Breast (Edinburgh, Scotland). 2011;20(3):254–8.

Article  Google Scholar 

Howard AF, Bottorff JL, Balneaves LG, Kim-Sing C. Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy. BMC Womens Health. 2010;10:24.

Article  Google Scholar